Default Category
-
Cancer Screening in Japan: Market Research and Segmentation
Quelch, John A.; Rodriguez, MargaretCase HBS-514057-EMarketingSince founding CancerScan in 2008, Jun Fukuyoshi and Yoshiki Ishikawa had helped to improve cancer screening rates in Japan. Between 2005 and 2007, awareness of breast cancer in Japan rose from 55% to 70%, but the incidence of breast cancer screenings remained constant. Jun and Yoshiki applied marketing research techniques to increase the screening rate for breast cancer, a disease which killed over 12,000 Japanese women in 2011. Cancer screening...Starting at €8.20
-
Vision 2020: Takeda and the Vaccine Business
Quelch, John A.; Rodriguez, MargaretCase HBS-514084-EMarketingTo maximize their effectiveness, color cases should be printed in color. In 2014, Yasuchika Hasegawa was orchestrating the transformation of Takeda from a Japanese pharmaceutical company with a global footprint into a global company with a Japanese heritage. A 33-year veteran of Takeda, Hasegawa-san was appointed president of Takeda in 2003 and chief executive in 2009. By 2013, Takeda was in the midst of implementing its new Vision 2020 plan, a s...Starting at €8.20
-
Gera Developments: Leadership at a Crossroads, Teaching Plan
Wing, Christina R.; Masko, JohnTeaching Note HBS-621109-EKnowledge and CommunicationTeaching plan for case 621018.Starting at €0.00
-
Uber: Competing Globally
MacKay, Alexander J.; Migdal, Amram; Masko, JohnCase HBS-720404-EStrategyThis case describes Uber's global market entry strategy and responses by regulators and local competitors. It details Uber's entry into New York City (United States), Bogot (Colombia), Delhi (India), Shanghai (China), Accra (Ghana), and London (United Kingdom). In each instance, the case includes information about Uber's strategy in that market, existing regulations on taxis and transportation in each market, the reactions of competitors and re...Starting at €8.20
-
Huawei and the U.S.-China Trade War
Ofek, Elie; Masko, JohnCase HBS-520017-EEconomicsIn 2019, Chinese smartphone maker and telecommunications empire Huawei was preparing to launch its new flagship smartphone series, the Mate 30. After years of explosive growth, the previous 18 months had been a challenge for the company. In early 2018, Huawei's planned smartphone launch in the U.S. had failed due to pressure from regulators who cited concerns about the company facilitating Chinese spying. Over the following months, a trade war be...Starting at €8.20
-
The Slingshot: Improving Water Access
Quelch, John A.; Knoop, Carin-Isabel; Rodriguez, MargaretCase HBS-514007-EMarketingTo maximize their effectiveness, color cases should be printed in color. In 2012, over 750 million people around the globe lacked access to safe drinking water. Dean Kamen, inventor of the Segway, sought to bring fresh water to poor and rural areas with the Slingshot, a water purification device. Kamen's challenge was to identify ways to distribute the Slingshot to areas where it was most needed. A partnership with the Coca-Cola Company helped Ka...Starting at €8.20
-
Rana Plaza: Workplace Safety in Bangladesh (A) and (B), Teaching Note
Quelch, John A.; Rodriguez, MargaretTeaching Note HBS-514062-EMarketingTeaching Note for 514034 and 514035.Starting at €0.00
-
Rana Plaza: Workplace Safety in Bangladesh (B)
Quelch, John A.; Rodriguez, MargaretCase HBS-514035-EMarketingIn the aftermath of the Rana Plaza building collapse, a group of international retailers and labor unions partnered to create a proposal for more stringent inspections and enforcement of safety standards in Bangladesh garment factories. The proposal was met by opposition from several U.S. firms, which claimed the proposal carried too a high a risk of litigation for them to sign. Neither proposal relied on legislation, but options for government i...Starting at €5.74
-
GlaxoSmithKline in China (A)
Quelch, John A.; Rodriguez, MargaretCase HBS-514049-EMarketingFour GlaxoSmithKline employees were accused of bribing Chinese health care workers to prescribe the company's drugs. The accusations brought to light the questionable incentive structures of the Chinese health care system and the pressure on companies to adhere to local customs while still observing local laws.Starting at €8.20
-
GlaxoSmithKline in China (B)
Quelch, John A.; Rodriguez, MargaretCase HBS-514050-EMarketingIn 2013, Chinese investigators detained four GSK employees for allegedly bribing health care staff to sell GSK pharmaceuticals. A month later, GSK's Asia Pacific regional president, Abbas Hussain, said the company would help identify corrupt practices. Two days later, GSK's CEO, Andrew Witty, called the allegations "shameful" and said the company would use the opportunity to "make changes."Starting at €5.74